Total SNPs with genotype data: 166

rs1799853 (CYP2C9)
  CC: Normal metabolism (*1/*1) - standard dosing
  CT: Intermediate (*1/*2) - ~20% reduced metabolism, may need 15-30% lower dose
  TT: Reduced metabolism (*2/*2) - ~40% reduction, may need 40-50% lower dose

rs1057910 (CYP2C9)
  AA: Normal metabolism (*1/*1)
  AC: Intermediate (*1/*3) - lower dose needed
  CC: Poor metabolism (*3/*3) - much lower dose

rs4244285 (CYP2C19)
  AA: Poor metabolizer (*2/*2) - may need alternative drug
  AG: Intermediate (*1/*2) - reduced effectiveness
  GG: Normal metabolizer (*1/*1) - standard effectiveness

rs4986893 (CYP2C19)
  AA: Poor metabolizer (*3/*3)
  GA: Intermediate (*1/*3)
  GG: Normal (*1/*1)

rs12248560 (CYP2C19)
  CC: Normal metabolism
  CT: Increased activity (*1/*17)
  TT: Ultra-rapid (*17/*17) - higher SSRI side effects

rs1065852 (CYP2D6)
  CC: Normal metabolizer
  CT: Intermediate
  TT: Poor metabolizer (*4/*4) - high drug sensitivity

rs3745274 (CYP2B6)
  GG: Normal metabolizer
  GT: Intermediate (*1/*6) - may have altered efavirenz response
  TT: Slow metabolizer (*6/*6) - reduced enzyme activity, higher side effects, lower d...

rs1801133 (MTHFR)
  CC: Normal enzyme function
  CT: Reduced function (~65% activity)
  TT: Low function (~10-20%) - need higher folate, dose adjustment

rs1801131 (MTHFR)
  AA: Normal function
  AC: Slightly reduced (~80% activity)
  CC: Mildly reduced function (~60% activity)

rs1045642 (ABCB1)
  CC: Normal drug metabolism, cannabis dependence risk, lower cancer risk
  CT: Slower metaboliser for some drugs
  TT: Altered drug metabolism/bioavailability, moderately increased cancer risk

rs1142345 (TPMT)
  AA: Normal TPMT activity
  AG: Intermediate activity - lower dose needed
  GG: Low activity - much lower dose or alternative

rs1801280 (NAT2)
  CC: Slow acetylator (higher drug side effects)
  TC: Intermediate acetylator
  TT: Normal/rapid acetylator

rs4149056 (SLCO1B1)
  CC: Reduced function - high myopathy risk (~17x)
  TC: Intermediate function - higher myopathy risk
  TT: Normal function

rs9923231 (VKORC1)
  CC: Normal warfarin sensitivity - standard dosing
  CT: Increased sensitivity - reduced warfarin dose needed
  TT: High sensitivity - significantly reduced dose needed, higher bleeding risk

rs429358 (APOE)
  CC: TWO Îµ4 copies (Îµ4/Îµ4) - very high risk - see full interpretation below
  CT: ONE Îµ4 allele - see combined interpretation with rs7412 below
  TT: No Îµ4 allele - see combined interpretation with rs7412 below

rs7412 (APOE)
  CC: No Îµ2 allele - see combined interpretation with rs429358 below
  CT: ONE Îµ2 allele - see combined interpretation with rs429358 below
  TT: TWO Îµ2 alleles - see combined interpretation with rs429358 below

rs1333049 (CDKN2A/B)
  CC: Elevated CAD/MI risk (~1.9x, +50% vs GG)
  CG: Moderate CAD risk (~1.5x, +25% vs GG)
  GG: Lower CAD risk (protective)

rs6025 (F5)
  AA: Homozygous (11.4x risk) - very rare
  GA: Factor V Leiden heterozygous (3.5-4.4x DVT risk)
  GG: Normal clotting

rs1799963 (F2)
  AA: Homozygous - very rare, very high risk
  GA: Carrier (2-3x clot risk)
  GG: Normal clotting

rs1800562 (HFE)
  AA: At risk for iron overload
  GA: Carrier (usually asymptomatic)
  GG: Normal iron regulation

rs1799945 (HFE)
  CC: Normal
  CG: Carrier (mild effect)
  GG: Two copies (mild iron overload risk)

rs7903146 (TCF7L2)
  CC: Typical risk
  CT: Elevated risk (OR ~1.4)
  TT: Higher risk (OR ~2.0)

rs9939609 (FTO)
  AA: Higher BMI tendency (+3-4kg)
  TT: Lower BMI tendency

rs1801282 (PPARG)
  CC: Normal fat metabolism (Pro/Pro)
  CG: Pro/Ala - altered metabolism (conflicting evidence)
  GG: Ala/Ala - altered metabolism (conflicting evidence)

rs5219 (KCNJ11)
  CC: Typical risk
  CT: Slightly elevated
  TT: Elevated risk

rs10830963 (MTNR1B)
  CC: Normal
  CG: Elevated fasting glucose
  GG: Higher glucose, T2D risk

rs738409 (PNPLA3)
  CC: Normal risk (wild-type)
  CG: Elevated NAFLD risk (~2x)
  GG: High NAFLD/cirrhosis/HCC risk (I148M homozygous)

rs780094 (GCKR)
  CC: Normal
  CT: Moderately elevated triglycerides
  TT: Higher triglycerides, NAFLD risk

rs5128 (APOC3)
  CC: Typical levels
  CG: Slightly elevated
  GG: Higher triglyceride tendency

rs662799 (APOA5)
  AA: Typical triglycerides (protective)
  AG: Elevated triglycerides (+11% per G allele)
  GG: Higher triglycerides (+36%), lower HDL, increased CVD risk

rs2383206 (CDKN2A/B)
  AA: Elevated risk
  AG: Moderate risk
  GG: Lower risk

rs1800795 (IL6)
  CC: Higher IL-6, inflammation
  GC: Moderate
  GG: Lower IL-6 production

rs1042522 (TP53)
  CC: Pro/Pro - may live ~3 years longer, better chemo response
  CG: Arg/Pro - intermediate
  GG: Arg/Arg - common variant, slightly shorter lifespan

rs17849079 (PIK3CA)
  GG: Normal risk
  GT: Slightly elevated risk
  TT: Elevated risk

rs2227983 (EGFR)
  AA: Higher lung cancer risk if smoker
  AG: Moderate protection
  GG: Better protection against lung cancer

rs4073 (CXCL8)
  AA: Lower IL-8
  TT: Higher IL-8, increased cancer risk

rs1800896 (IL10)
  AA: Higher IL-10 (protective)
  AG: Moderate
  GG: Lower IL-10

rs4986790 (TLR4)
  AA: Normal response
  AG: Altered immune response
  GG: Different response pattern

rs10490770 (LZTFL1)
  AA: Lower risk of severe COVID
  AG: Moderate risk (~1.7x)
  GG: 2x risk of severe COVID-19

rs657152 (ABO)
  AA: Blood type A (higher COVID risk)
  AC: Blood type A or AB
  CC: Blood type O (lower COVID risk)

rs2476601 (PTPN22)
  AA: Higher autoimmune risk
  AG: Elevated autoimmune risk
  GG: Typical risk

rs1800629 (TNF)
  AA: Much higher TNF (pro-inflammatory)
  GA: Higher TNF production
  GG: Normal TNF levels

rs2187668 (HLA-DQA1)
  CC: Very low risk (<1%)
  CT: Low-moderate risk
  TT: Elevated risk

rs6457620 (HLA region)
  CC: Lower risk
  CT: Moderate risk
  TT: Higher RA risk

rs2234693 (ESR1)
  CC: Lower bone density tendency
  CT: Moderate
  TT: Better bone density

rs4293393 (UMOD)
  AA: Elevated CKD risk, salt-sensitive hypertension (T/T on research strand)
  AG: Moderate CKD risk
  GG: Lower CKD risk (protective, C/C on research strand, lower uromodulin)

rs1799983 (NOS3)
  GG: Normal NO production
  GT: Slightly reduced
  TT: Lower NO, hypertension risk

rs2802292 (FOXO3)
  GG: Typical lifespan
  GT: âœ“ MODERATE longevity (~1.3x centenarian odds) - good aging trajectory
  TT: ðŸŒŸ STRONG longevity (~1.8x centenarian odds) - stress resistance, healthy aging

rs2764264 (FOXO3)
  CC: Typical lifespan
  CT: âœ“ MODERATE longevity association
  TT: ðŸŒŸ STRONG longevity association

rs429358 (APOE)
  CC: âš âš  TWO Îµ4 copies = Îµ4/Îµ4 - very high Alzheimer risk (~12x, 61x early-onset), ver...
  CT: ONE Îµ4 allele (need rs7412: if CT=Îµ2/Îµ4 [~2.6x risk], if CC=Îµ3/Îµ4 [~3.2x risk])
  TT: No Îµ4 allele (need rs7412: if TT=Îµ2/Îµ2 [0.6x risk], if CT=Îµ2/Îµ3 [0.6x risk], if ...

rs7412 (APOE)
  CC: No Îµ2 allele (need rs429358: if TT=Îµ3/Îµ3 [1.0x risk], if CT=Îµ3/Îµ4 [~3.2x risk], ...
  CT: ONE Îµ2 allele (need rs429358: if TT=Îµ2/Îµ3 [0.6x risk], if CT=Îµ2/Îµ4 [~2.6x risk])
  TT: TWO Îµ2 alleles (need rs429358: if TT=Îµ2/Îµ2 [0.6x risk, longevity])

rs4420638 (APOE region)
  AA: âœ“ Normal/average Alzheimer risk
  AG: âš  Elevated Alzheimer risk (~3x), higher heart disease risk (1.4x)
  GG: âš  Higher Alzheimer risk (2x+), higher LDL cholesterol

rs3764261 (CETP)
  AA: âœ“ Lower CETP activity - higher HDL ("good" cholesterol), longevity association
  CA: Reduced CETP activity - higher HDL
  CC: Typical CETP activity - typical HDL levels

rs9536314 (KLOTHO)
  GG: KL-VS homozygote - may reduce lifespan (rare)
  GT: âœ“ KL-VS heterozygote - better cognition, may enhance longevity
  TT: Typical klotho function

rs2802288 (Unknown)
  GG: GG
  GT: GT
  TT: TT

rs2764264 (Unknown)
  CC: GG
  CT: GT
  TT: TT

rs12202234 (Unknown)
  CC: GG
  CT: GT
  TT: TT

rs3800230 (Unknown)
  AA: TT
  AG: GT
  GG: GG

rs4680_cognition (COMT)
  AA: Met/Met - "Worrier" - better memory, attention, information processing under nor...
  GA: Val/Met - intermediate cognitive performance
  GG: Val/Val - "Warrior" - modest reduction in executive function, better under stres...

rs1006737_cognition (CACNA1C)
  AA: Impaired working memory, reduced prefrontal efficiency
  AG: Intermediate working memory
  GG: Better working memory performance

rs1044396 (CHRNA4)
  CC: Reduced parietal cortex activity during attention tasks
  CT: Intermediate attention performance
  TT: Robust parietal cortex activity, enhanced attention and working memory

rs17070145 (KIBRA)
  CC: Reduced memory abilities
  CT: Increased memory performance (T allele +24% recall)
  TT: Greatly increased memory performance

rs6265_cognition (BDNF)
  AA: Met/Met - reduced learning efficiency, faster cognitive decline with age
  GA: Val/Met - impaired motor learning, reduced BDNF secretion
  GG: Val/Val - better learning, memory, neuroplasticity

rs11136000 (CLU)
  CC: Higher risk - accelerated cognitive decline, poorer memory scores, faster MCIâ†’AD...
  CT: Intermediate risk - faster memory decline in presymptomatic stages
  TT: Lower risk of cognitive decline, better memory maintenance

rs9331896 (CLU)
  CC: Lower Alzheimer\
  CT: Intermediate risk of cognitive decline (OR 1.18)
  TT: Higher AD risk, faster presymptomatic memory decline, altered hippocampal CLU ex...

rs363050 (SNAP25)
  AA: Original (unreplicated) study suggested +2.8 PIQ vs GG
  AG: Intermediate (unreplicated findings)
  GG: Reference genotype (note: original IQ findings did not replicate)

rs6746030 (SCN9A)
  AA: Lower pain sensitivity
  GA: Reduced pain sensitivity
  GG: Normal pain sensitivity

rs6267 (COMT)
  GG: Common genotype (~83% frequency, research on schizophrenia association is inconc...
  GT: Less common (~16%, TT genotype codes for similar enzyme activity as GT)
  TT: Rare genotype (~1%, research on schizophrenia association is inconclusive)

rs1799971_pain (OPRM1)
  AA: Normal pain response, better opioid effect
  AG: Intermediate
  GG: Higher pain sensitivity, reduced opioid efficacy

rs1800497_addiction (DRD2)
  CC: Normal D2 receptors
  CT: Reduced receptors - addiction risk
  TT: Low D2 - higher addiction/substance abuse risk

rs279858 (GABRA2)
  AA: Lower alcoholism risk
  AG: Elevated risk (slower alcohol response)
  GG: Higher alcoholism risk (slower alcohol response)

rs2023239 (CNR1)
  CC: Typical
  CT: Moderate risk
  TT: Higher cannabis dependence risk

rs806378 (CNR1)
  CC: Lower risk
  CT: Moderate
  TT: Elevated addiction risk

rs324420_addiction (FAAH)
  AA: Significantly increased substance use disorder risk
  CA: Intermediate
  CC: Normal risk

rs6295 (HTR1A)
  CC: Normal receptor function
  CG: Altered SSRI response
  GG: Lower expression, depression/anxiety risk

rs6313 (HTR2A)
  AA: Poorer SSRI response
  GA: Intermediate
  GG: Better SSRI response

rs7997012 (HTR2A)
  AA: 18% better response to citalopram
  AG: Normal response
  GG: 18% worse response to citalopram

rs6311 (HTR2A)
  CC: 3.6x risk of sexual dysfunction on SSRIs, higher suicide risk
  CT: Normal risk
  TT: Normal (lower) risk of SSRI sexual dysfunction, protective against suicide

rs4570625 (TPH2)
  GG: Higher anxiety-related traits, greater placebo response
  GT: Normal
  TT: Normal

rs25531 (SLC6A4)
  AA: Lower serotonin, slightly less happy, may need more support
  AG: Intermediate
  GG: More resilient to stress, optimistic, higher life satisfaction

rs25532 (SLC6A4)
  CC: Higher expressing allele, may be part of OCD haplotype
  CT: May be part of OCD haplotype
  TT: Normal

rs4680 (COMT)
  AA: Met/Met - slow clearance (Worrier, anxious, better cognition)
  GA: Val/Met - intermediate
  GG: Val/Val - fast clearance (Warrior, stress-resilient)

rs6269 (COMT)
  AA: Lower COMT activity
  AG: Intermediate
  GG: Higher activity

rs4633 (COMT)
  CC: Normal cancer risk (magnitude 0)
  CT: Higher endometrial cancer risk (magnitude 2)
  TT: Higher endometrial cancer risk (magnitude 2, OR 2.39)

rs165599 (COMT)
  AA: Lower risk (magnitude 0)
  GA: Moderate risk (magnitude 1)
  GG: Elevated risk (magnitude 1.5)

rs1800497 (DRD2)
  CC: Normal D2 density
  CT: Reduced receptor (reward deficiency)
  TT: Lower D2 (addiction/impulse risk)

rs6277 (DRD2)
  CC: Higher D2 expression, 1.6x schizophrenia risk
  CT: Intermediate D2 expression, 1.4x schizophrenia risk
  TT: Lower D2 expression (T allele decreases mRNA), normal schizophrenia risk

rs1076560 (DRD2)
  AA: Altered working memory
  AC: Moderate (1.3x alcoholism risk)
  CC: Typical

rs1800955 (DRD4)
  CC: Increased novelty-seeking susceptibility
  CT: Increased novelty-seeking susceptibility
  TT: Normal

rs936461 (DRD4)
  AA: ADHD association
  GA: Moderate
  GG: Typical

rs1611115 (DBH)
  CC: Highest DBH enzyme activity (~48.1)
  CT: Intermediate activity (~25.2)
  TT: Lowest DBH enzyme activity (~4.1), ADHD/impulsiveness risk

rs1108580 (DBH)
  AA: Reference/common genotype
  GA: Heterozygous
  GG: Variant genotype (non-pathogenic)

rs6265 (BDNF)
  AA: Met/Met - reduced BDNF, impaired memory but may be depression resistant
  GA: Val/Met - intermediate, impaired motor learning
  GG: Val/Val - better memory, learning

rs11030104 (BDNF)
  AA: Higher BMI tendency (A is risk allele)
  AG: Moderate BMI increase, may affect Alzheimer (non-ApoE4)
  GG: Lower BMI tendency

rs908867 (BDNF)
  CC: Lower expression
  CT: Intermediate
  TT: Higher BDNF expression (protective)

rs1006737 (CACNA1C)
  AA: Higher bipolar/depression risk (~1.2x)
  AG: Elevated risk (~1.1x)
  GG: Typical risk

rs10994336 (ANK3)
  CC: Typical risk
  CT: Elevated bipolar risk (1.45x)
  TT: Higher bipolar risk (2.9x)

rs10994397 (ANK3)
  CC: Typical risk
  CT: Elevated risk
  TT: Higher risk

rs1344706 (ZNF804A)
  AA: 1.2x increased schizophrenia risk
  AC: 1.1x increased schizophrenia risk
  CA: 1.1x increased schizophrenia risk
  CC: Normal risk
  GG: Normal risk
  GT: 1.1x increased schizophrenia risk
  TT: 1.2x increased schizophrenia risk

rs3924999 (NRG1)
  AA: Research on schizophrenia risk is mixed/inconclusive
  AG: Research on schizophrenia risk is mixed/inconclusive
  GG: Research on schizophrenia risk is mixed/inconclusive

rs17512836 (TCF4)
  CC: Elevated schizophrenia risk
  TC: Moderate risk (OR 1.23)
  TT: Lower risk

rs324420 (FAAH)
  AA: Slow FAAH breakdown - higher pain tolerance, national happiness correlation BUT ...
  CA: Intermediate
  CC: Fast FAAH breakdown (typical)

rs53576 (OXTR)
  AA: Lower sensitivity (less empathetic, higher stress)
  GA: Intermediate
  GG: Higher sensitivity (more empathetic, handle stress well)

rs2254298 (OXTR)
  AA: Altered social behavior, autism association
  GA: Moderate
  GG: Typical social behavior

rs237887 (OXTR)
  AA: Typical
  AG: Moderate
  GG: Altered social processing

rs2268498 (OXTR)
  CC: Common variant
  CT: Heterozygous
  TT: Homozygous variant (may affect social perception)

rs13212041 (HTR1B)
  AA: Lower anxiety
  AG: Moderate
  GG: Higher anxiety tendency

rs3813034 (SLC6A4)
  AA: Less common variant
  CA: Heterozygous
  CC: Probable non-pathogenic

rs1799971 (OPRM1)
  AA: Normal opioid response
  AG: Reduced receptor function
  GG: Lower receptor density, higher addiction risk

rs12922317 (SNX29)
  AA: Less common genotype (limited research)
  GA: Heterozygous
  GG: Common genotype

rs4675690 (CREB1)
  CC: Typical
  CT: Moderate
  TT: Altered function

rs2049045 (BDNF)
  CC: Common genotype
  CG: Heterozygous
  GG: Less common (limited research)

rs1801131_mood (MTHFR)
  AA: Normal
  AC: Slightly reduced
  CC: Reduced function, mood impact

rs12913832 (HERC2)
  AA: Brown eyes (>95%)
  AG: Brown/green (mixed)
  GG: Blue eyes (>90%)

rs1800407 (OCA2)
  AA: Darker eyes (brown/black)
  AG: Mixed (hazel/green)
  GG: Lighter eyes (blue/gray)

rs16891982 (SLC45A2)
  CC: Darker
  CG: Mixed
  GG: Lighter

rs1393350 (TYR)
  AA: Lighter eyes (blue), blond hair
  AG: Lighter eyes tendency
  GG: Darker eyes (brown)

rs12896399 (SLC24A4)
  GG: Dark hair
  GT: Mixed
  TT: Light hair

rs1805007 (MC1R)
  CC: Non-red
  CT: Red hair carrier
  TT: Red hair likely

rs1805008 (MC1R)
  CC: Non-red
  CT: Carrier
  TT: Red hair

rs1805009 (MC1R)
  CC: Non-red
  CT: Carrier
  TT: Red hair

rs11547464 (MC1R)
  AA: Red hair likely
  AG: Red hair carrier
  GG: Non-red hair

rs1110400 (MC1R)
  CC: Higher melanoma risk
  CT: Moderate risk
  TT: Lower risk

rs17646946 (TCHH)
  AA: Straight hair
  AG: Mixed
  GG: Curly/wavy

rs3827760 (EDAR)
  CC: Straight, thick hair
  CT: Mixed
  TT: Variable

rs1426654 (SLC24A5)
  AA: Lighter skin (European ancestry)
  AG: Intermediate
  GG: Darker skin (African/Asian ancestry)

rs12203592 (IRF4)
  CC: No freckles
  CT: Some freckles
  TT: More freckles

rs1815739 (ACTN3)
  CC: Fast-twitch (RR - sprinter)
  CT: Mixed (RX)
  TT: Endurance (XX - no alpha-actinin-3)

rs8111989 (NFIA)
  AA: Endurance advantage
  AG: Mixed
  GG: Typical

rs1042713 (ADRB2)
  AA: Arg/Arg - 1.7x risk that pediatric inhaler use may worsen asthma
  AG: Gly/Arg - 1.3x risk that pediatric inhaler use may worsen asthma
  GG: Gly/Gly - normal (reference)

rs1042714 (ADRB2)
  CC: Gln/Gln - normal/baseline risk
  CG: Gln/Glu - complex (increased thromboembolism, autism risk)
  GG: Glu/Glu - complex (higher thromboembolism, autism, stroke; lower diabetes risk)

rs6570507 (ADGRG6)
  CC: Shorter tendency
  CT: Average
  TT: Taller tendency

rs1042725 (HMGA2)
  CC: Taller (+0.8cm)
  TC: Average (+0.4cm)
  TT: Shorter

rs17822931 (ABCC11)
  CC: Wet earwax, more body odor
  CT: Wet (carrier for dry)
  TT: Dry earwax, less body odor

rs4988235 (LCT)
  CC: Lactose intolerant (low lactase activity)
  CT: Likely tolerant (intermediate activity)
  TT: Lactose tolerant (can digest milk)

rs182549 (LCT)
  CC: Intolerant
  CT: Likely tolerant
  TT: Tolerant

rs713598 (TAS2R38)
  CC: Taster
  CG: Taster
  GG: Non-taster

rs1726866 (TAS2R38)
  CC: Taster
  CT: Taster
  TT: Non-taster

rs671 (ALDH2)
  AA: Very reduced (strong flush)
  GA: Reduced (flush reaction)
  GG: Normal metabolism

rs1229984 (ADH1B)
  AA: Typical
  AG: Faster
  GG: Fast (protective against alcoholism)

rs762551 (CYP1A2)
  AA: Fast metabolizer (especially in smokers/heavy coffee drinkers)
  AC: Normal metabolism
  CC: Normal metabolism

rs2472297 (Between CYP1A1/CYP1A2)
  CC: Fast
  CT: Intermediate
  TT: Slower

rs16969968 (CHRNA5)
  AA: Higher dependence risk
  AG: Moderate
  GG: Lower risk

rs1051730 (CHRNA3)
  CC: Lower risk (fewer cigarettes if smoker)
  CT: Moderate (1.3x lung cancer risk)
  TT: Higher risk (1.8x lung cancer risk)

rs72921001 (OR6A2)
  AA: Normal taste
  AG: May taste soapy
  GG: Soapy taste

rs4481887 (Intergenic)
  AA: Can smell
  AG: Can smell
  GG: Cannot smell

rs1801260 (CLOCK)
  CC: Strong evening preference (delayed sleep ~79min, less sleep ~75min)
  CT: Moderate evening preference
  TT: Normal/typical sleep pattern

rs73598374 (ADA)
  AA: Less deep sleep
  AG: Normal
  GG: More deep sleep

rs2292912 (CRY2)
  CC: Morning person
  CT: Intermediate
  TT: Evening person

rs4588 (GC)
  AA: Lower vitamin D levels (A allele associated with ~10-15% lower 25(OH)D)
  CA: Intermediate vitamin D levels
  CC: Higher vitamin D levels (C allele associated with ~10-15% higher 25(OH)D)

rs2282679 (GC)
  GG: Lower levels
  GT: Moderate
  TT: Higher levels

rs601338 (FUT2)
  AA: Non-secretor (higher plasma B12 levels)
  AG: Intermediate
  GG: Secretor (lower plasma B12 levels)

rs4654748 (NBPF3)
  CC: Lower B6 levels (-1.45 to -2.90 ng/mL)
  CT: Moderate B6 levels
  TT: Higher B6 levels

rs1815739_athletic (ACTN3)
  CC: RR - Power/sprint athlete advantage
  CT: RX - Mixed performance
  TT: XX - Endurance athlete advantage

rs8192678 (PPARGC1A)
  CC: Better aerobic capacity
  CT: Intermediate
  TT: Lower VÌ‡O2max response to training

rs1572312 (NFIA-AS2)
  AA: Alternative genotype
  CA: Heterozygous
  CC: Common genotype

rs699 (AGT)
  CC: Higher blood pressure, power athlete association
  CT: Intermediate
  TT: Lower blood pressure

rs1800975 (MMP1)
  AA: Higher collagen breakdown, premature aging
  GA: Moderate
  GG: Lower collagen breakdown

rs1800012 (COL1A1)
  GG: Normal collagen
  GT: Stronger collagen (Sp1 site)
  TT: Strongest collagen, better bone density

rs1126809 (TYR)
  AA: Gln/Gln - slight increase in skin cancer risk
  GA: Arg/Gln - slight increase in skin cancer risk
  GG: Arg/Arg - normal melanoma risk

rs307355 (TAS1R3)
  CC: Normal sweet perception
  CT: Reduced sweet sensitivity
  TT: Lower sweet taste sensitivity

rs35874116 (TAS1R2)
  AA: Normal
  AG: Altered sweet perception
  GG: Reduced sweet taste

rs846664 (TRPV1)
  AA: Higher spice tolerance
  AG: Moderate
  GG: Lower spice tolerance

rs1801282_thermo (PPARG)
  CC: Higher fat storage tendency
  CG: Moderate
  GG: Better thermogenesis, lower fat storage

rs1800592 (UCP1)
  AA: Higher thermogenesis, better cold tolerance
  GA: Moderate
  GG: Lower thermogenesis

rs659366 (UCP2)
  AA: Higher energy expenditure
  AC: Moderate
  CC: Lower energy expenditure, obesity risk

